FiercePharmaOriginal article
{"a":[{"_":"Pursuing patient options, Novo kicks off trial testing smaller doses of Wegovy pill","$":{"href":"/pharma/novo-nordisk-kicks-trial-testing-smaller-doses-wegovy-pill","hreflang":"en"}}]}
Phase 3WegovyNeutral
AI Analysis
Summary
Novo Nordisk has initiated the Phase 3 OASIS 5 trial to evaluate smaller doses of its Wegovy oral pill, eight months after its market introduction.
Clinical Trial Data
Phase
Phase 3
Importance:5/10
Sentiment:
0.00
GLP-1oral formulationdose optimizationOASIS 5
Related Companies
Read the original article
Published by FiercePharma on August 19, 2026 3:04 PM
